Atlas Trials

A Study to Evaluate Safety, PK and PD of FDL169 in Cystic Fibrosis Subjects

Clinical trial NCT03093714 · COMPLETED

Trial details

NCT number
NCT03093714
Sponsor
Flatley Discovery Lab LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Cystic Fibrosis
Start date
2017-08-23
Primary completion
2018-04-03
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.